RA Capital β Full Portfolio
272 tracked investments Β· page 2 of 2 Β· listed companies and verified rows first
BiotechScotch Plains, US
STEPHEN BASIL THOMAS(Executive Officer, Director, Promoter)WILLIAM DALEY BONIFICIO(Executive Officer, Promoter)NAVEEN MANU DARYANI(Executive Officer)
BoardANDREW LEVIN(Director)WOUTER JOUSTRA(Director)
Nextop IO provides a mobile content delivery network with a client-side library for iOS and Android that routes traffic through optimized proxy servers, reducing latency, improving throughput, and lowering data and battery consumption for mobile applications connecting to backend services.
Data & InfrastructureDeveloper ToolsEnterprise Software
Brien Colwell(Founder/CEO)in
NiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2Ξ±, CDK2, and KRAS targets using structure-based drug design.
Biotech
Harnesses cutting-edge technologies to design exquisitely selective small molecule therapeutics.
BiotechCambridge, US
Douglas A. Treco(Executive Officer, Director)Edward Mathers(Director)Peter Bisgaard(Director)Jason Lettman(Director)Kerry Black(Executive Officer)Markus Goebel(Director)
BiotechDallas, US
ANGELA SHEN(Director)HENRIK RASMUSSEN(Director)VINEET JINDAL(Executive Officer, Director)SUNJAY KAUSHAL(Director)WILLIAM NILAND(Director)
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
ARS Pharma develops needle-free epinephrine therapy, marketing neffy, an FDA-approved epinephrine nasal spray designed to be easy to carry and use.
BiotechDigital HealthMedical DevicesSeattle, US
Peter A. Thompson(Executive Officer, Director)
BiotechBoston, US
Sara Pacheco(Executive Officer)Neil Buckley(Executive Officer, Director)Gregory Frank Oakes(Executive Officer)
BoardTim Lohoff(Director)Cindy Xiong(Director)Andrew Levin(Director)
Somatus provides clinical, emotional, and social support to patients with kidney and heart disease.
Digital HealthHealthtechMclean, US
Anthony Welters(Director)Alexander Houlday(Executive Officer)Ikenna Okezie(Executive Officer, Director)Stacey Queen-Pyndell(Executive Officer)
BoardAnna Haghgooie(Director)
Markle, US
Nalin Kumar(Executive Officer, Director)Michael Siemer(Executive Officer, Director)Curt Sacks(Executive Officer)Benjamin Pope(Executive Officer)
BoardAlfred Lam(Director)Kyle Teamey(Director)
Sparrow Pharma develops targeted cardiometabolic therapeutics for patients with type 2 diabetes, focusing on cortisol regulation through HSD-1 inhibition.
BiotechHealthtechMedical DevicesPortland, US
Robert Jacks(Executive Officer, Director)David Aaron Katz(Executive Officer, Director)
BoardJonathan Root(Director)Niall O'Donnell(Director)Zach Scheiner(Director)Klaus Veitinger(Director)
Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.
BiotechDigital HealthMedical Devices
Michael C. Bassik, Ph.D.(Scientific Founder)inEmile Nuwaysir, Ph.D.(Chairman & Chief Executive Officer)inJason Fontenot, Ph.D.(Chief Scientific Officer)
Clinical-stage biotech expanding the genetic alphabet with synthetic nucleotides; acquired by Sanofi for $2.5B in 2020.
La Jolla, US
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)Erwin Berthier(Co-Founder and Chief Technology Officer)Alan Levy(Director)
BoardElizabeth Hambrecht(Director)Paul Conley(Director)
BiotechSouth San Francisco, US
Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)
BoardMichael Goller(Director)Reid Huber(Director)Peter Thompson(Director)
Terrestrial develops the Tacterra microarray patch platform to deliver a wide range of therapies, including GLP-1, through the skin using dissolvable tipsβeliminating needles and refrigeration requirements.
BiotechDigital HealthMedical Devices
Rachel Sha(CEO)
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechWaltham, US
Judith Lieberman(Co-Founder, MD, PhD)Daniel Koerwer(Executive Officer)Josh Resnick(Director)Steven James(Director)Michael Crackower(Executive Officer)Zachary McNealy(Executive Officer)
BiotechCambridge, US
Andrew Ashe(Executive Officer)Burt Adelman(Director)John Evans(Director)Sekar Kathiresan(Executive Officer, Director)Andrew Bellinger(Executive Officer)
BoardAnthony Philippakis(Director)
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Sandra Poole(Director)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Lucian Iancovici(Director)Steve White(Executive Officer)
BiotechBoulder, US
Theodore Randolph(Director)Romulo Colindres(Executive Officer, Director, Promoter)
BoardGlenn Rockman(Director)Rene Lorenz(Director)Louise Brady(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.
